secwatch.observer — SEC 8-K summary
======================================

Issuer:     Definium Therapeutics, Inc. (DFTX)
CIK:        0001813814
Form:       8-K
Filed at:   2023-06-15T23:59:59+00:00
Accession:  0000950170-23-028341
Event type: other_material
Sentiment:  negative
Materiality: 0.65
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

MindMed adjourns annual meeting due to lack of quorum; accuses FCM of deliberate obstruction
--------------------------------------------------------------------------------

- Annual meeting on June 15, 2023 adjourned without business due to absence of required 33⅓% quorum.
- Reconvened meeting set for June 21, 2023 at 10:00 a.m. ET; virtual format unchanged.
- Company alleges FCM MM Holdings deliberately acted to prevent quorum and shareholder voting.
- If quorum still absent at reconvened meeting, attendees present will constitute quorum per Articles.
- New proxy deadline June 19, 2023; company urges vote FOR all six Board nominees on WHITE card.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1813814/000095017023028341/0000950170-23-028341-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1813814/000095017023028341/mnmd-20230615.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-028341

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer